Warning Letter — Next Medical Products Company, LLC
The FDA issued a Warning Letter to Next Medical Products Company, LLC following an inspection by the Center for Devices and Radiological Health (CDRH).
This affects Next Medical Products Company, LLC and its internal departments responsible for regulatory compliance, quality systems, and manufacturing oversight.
A Warning Letter from CDRH indicates that the agency identified significant violations of regulatory requirements during its inspection. This suggests that the firm's current quality or manufacturing controls may be insufficient to meet FDA standards, potentially leading to further enforcement actions if not remediated.
Quality and Regulatory teams should review existing quality management systems for gaps identified in recent CDRH inspections. Ensure all manufacturing processes and documentation align with current regulatory expectations to mitigate risk of similar enforcement actions.
FDA Warning Letter issued to: Next Medical Products Company, LLC. 08/19/2026 — Center for Devices and Radiological Health. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/next-medical-products-company-llc-727918-08192026
Open in openFDA / FDA.gov